Molecularly Tailored Therapy for Pancreas Cancer

Completed · Phase 2

Conditions studied: Pancreatic Cancer

In brief

Patient therapy is tailored according to the molecular profile of the patient's tumor.

Key facts

Study ID
NCT01888978
Run by
Georgetown University
People needed
19
Starts
2012-12-01
Expected to finish
2018-01-24
Last updated by the study team
2018-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.